Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mitsuru, Segawa"'
Autor:
Yukio, Sakata, Hisaaki, Ariga, Akira, Sugiura, Yukiko, Saito, Keiko, Kamada, Mitsuru, Segawa, Shunsuke, Tsuji, Keigo, Matsuoka, Hirohito, Ishii, Yasuhide, Tsuji, Michiya, Kobayashi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(10)
While many studies have demonstrated the prevention of nausea and vomiting in patients receiving moderately or highly emetogenic anti-cancer agents, there are few reports of mildly emetogenic anti-cancer agents. In the present study, we performed a 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91d5b6c6fc2f2167701c9764065fc22b
https://pubmed.ncbi.nlm.nih.gov/31631138
https://pubmed.ncbi.nlm.nih.gov/31631138
Publikováno v:
Arzneimittelforschung. 57:92-100
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor currently under development for the treatment of overactive bladder. Affinities of imidafenacin and other drugs for muscarinic ACh rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a12a5b20712efc33cffc0e482542149
https://doi.org/10.1055/s-0031-1296589
https://doi.org/10.1055/s-0031-1296589
Autor:
Mitsuru Segawa, Shigeki Matsuzawa, Takanobu Yamazaki, Eiji Wakabayashi, Fumiyoshi Kobayashi, Masako Inoue, Yuichi Yageta
Publikováno v:
Arzneimittelforschung. 57:147-154
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) has been developed for the treatment of overactive bladder as a new anti-cholinergic with high affinities for muscarinic acetylcholine M3 and M1 receptors. The pharmacological profiles of imidafenacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f03a39d3d3fdba4602e2281d63969e2
https://doi.org/10.1055/s-0031-1296598
https://doi.org/10.1055/s-0031-1296598
Publikováno v:
Journal of Robotics and Mechatronics. 13:198-204
We propose a design concept and operation of a flexible robot with multiple degrees of freedom to dive into debris. Pneumatic robots with flexibility previously developed did not have multiple degrees of freedom with high bending moment. We propose a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbd6189b48d9c414f00f836599f39c49
https://doi.org/10.20965/jrm.2001.p0198
https://doi.org/10.20965/jrm.2001.p0198
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 8:2163-2168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::467c2aae15ecbe60e4b076f2ec8911d7
https://doi.org/10.1016/s0960-894x(98)00393-x
https://doi.org/10.1016/s0960-894x(98)00393-x
Publikováno v:
Japanese Journal of Tropical Medicine and Hygiene. 18:197-201
One case of human myiasis caused by Dermatobia hominis was reported.The patient was a 22-year-old Japanese woman who had been in Brazil for 12 years. She lives in the suburbs of Sao Paulo City at present.About the middle of December 1988, slight blee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d503ac28492204c7014bf1811a04554c
https://doi.org/10.2149/tmh1973.18.197
https://doi.org/10.2149/tmh1973.18.197
Autor:
Fumiyoshi, Kobayashi, Yuichi, Yageta, Takanobu, Yamazaki, Eiji, Wakabayashi, Masako, Inoue, Mitsuru, Segawa, Shigeki, Matsuzawa
Publikováno v:
Arzneimittel-Forschung. 57(3)
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) has been developed for the treatment of overactive bladder as a new anti-cholinergic with high affinities for muscarinic acetylcholine M3 and M1 receptors. The pharmacological profiles of imidafenacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef9d0982c9fdfc3726abb6631ebaa405
https://pubmed.ncbi.nlm.nih.gov/17469649
https://pubmed.ncbi.nlm.nih.gov/17469649
Publikováno v:
Arzneimittel-Forschung. 57(2)
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor currently under development for the treatment of overactive bladder. Affinities of imidafenacin and other drugs for muscarinic ACh rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c43fcf99d041c7e5d1bd36929e149073
https://pubmed.ncbi.nlm.nih.gov/17396619
https://pubmed.ncbi.nlm.nih.gov/17396619
Publikováno v:
Bioorganicmedicinal chemistry letters. 9(20)
A series of imidazolium salt derivatives was prepared as part of a search for subtype-selective antimuscarinic agents. On the basis of measurements of the antimuscarinic activity and subtype-selectivity for M2 and M3 muscarinic receptors, the structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bffa377d69fd5c68f6b2eaa48b2b46
https://pubmed.ncbi.nlm.nih.gov/10571164
https://pubmed.ncbi.nlm.nih.gov/10571164
Publikováno v:
Bioorganicmedicinal chemistry. 7(6)
In a study directed toward the development of new, selective agents with potential utility in the treatment of altered smooth muscle contractility and tone, for example, as seen in urinary incontinence associated with bladder muscle instability, a se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa9f6c65596f364e1f6c8821b7b7a800
https://pubmed.ncbi.nlm.nih.gov/10428387
https://pubmed.ncbi.nlm.nih.gov/10428387